l glutathione and fatty liver Combined Metabolic Activators Reduces Fat in Nonalcoholic Liver Disease Patients Although liver biopsy remains as
Description
doi:10.1038/nsmb.2081
doi: 10.1056/NEJMp1102155 43 RoqueP

Translational research must prioritize the development of validated biomarkers of MP exposure and toxicity, such as fecal or urinary MP levels, gut barrier integrity, and systemic inflammation markers

Feld, J

Wu Y, Zhao Y, Yang HZ, Wang YJ, Chen Y
